Compounds > acetylcysteine

acetylcysteine and Hepatic Veno Occlusive Disease

acetylcysteine has been researched along with Hepatic Veno Occlusive Disease in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's2 (33.33)24.3611
2020's2 (33.33)2.80

Authors

AuthorsStudies
C S, G; Rupakumar, T; T, PK; Tandra, HV; V R, P; Vijayasekharan, K1
Björklund, A; El-Serafi, I; Mattsson, J; Remberger, M; Ringdèn, O; Sundin, M; Törlén, J; Winiarski, J1
Aung, L; Lee, AC1
Sahoo, RK; Sharma, A1
Barkholt, L; Brune, M; Fransson, K; Hassan, M; Hassan, Z; Karlsson, H; Mattsson, J; Omazic, B; Remberger, M; Ringdén, O; Svahn, BM1
Aschan, J; Hentschke, P; Klaesson, S; Lehmann, S; Mattsson, J; Remberger, M; Ringdén, O1

Trials

1 trial(s) available for acetylcysteine and Hepatic Veno Occlusive Disease

ArticleYear
A prospective randomized study using N-acetyl-L-cysteine for early liver toxicity after allogeneic hematopoietic stem cell transplantation.
    Bone marrow transplantation, 2008, Volume: 41, Issue:9

    Topics: Acetylcysteine; Adolescent; Adult; Aged; Aspartate Aminotransferases; Bilirubin; Child; Child, Preschool; Female; Free Radical Scavengers; Hematopoietic Stem Cell Transplantation; Hepatic Veno-Occlusive Disease; Humans; Male; Middle Aged; Neoplasms; Prospective Studies; Time Factors; Transplantation, Homologous

2008

Other Studies

5 other study(ies) available for acetylcysteine and Hepatic Veno Occlusive Disease

ArticleYear
A stitch in time saves nine: timely use of N-acetyl cysteine (NAC) for chemotherapy-induced veno-occlusive disease (VOD)-is it a cost-effective alternative?
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2022, Volume: 30, Issue:11

    Topics: Acetylcysteine; Antineoplastic Agents; Child; Cost-Benefit Analysis; Hematopoietic Stem Cell Transplantation; Hepatic Veno-Occlusive Disease; Humans; Polydeoxyribonucleotides; Vascular Diseases

2022
Reduced Risk of Sinusoidal Obstruction Syndrome of the Liver after Busulfan-Cyclophosphamide Conditioning Prior to Allogeneic Hematopoietic Stem Cell Transplantation.
    Clinical and translational science, 2020, Volume: 13, Issue:2

    Topics: Acetylcysteine; Adolescent; Adult; Busulfan; Capillaries; Child; Child, Preschool; Cholagogues and Choleretics; Cyclophosphamide; Drug Monitoring; Female; Free Radical Scavengers; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hepatic Veno-Occlusive Disease; Humans; Incidence; Infant; Liver; Male; Middle Aged; Myeloablative Agonists; Retrospective Studies; Risk Assessment; Transplantation Conditioning; Ursodeoxycholic Acid; Young Adult

2020
Treatment of hepatic veno-occlusive disease in children with N-acetylcysteine.
    Pediatric blood & cancer, 2019, Volume: 66, Issue:2

    Topics: Acetylcysteine; Antineoplastic Agents; Child; Child, Preschool; Female; Free Radical Scavengers; Hematopoietic Stem Cell Transplantation; Hepatic Veno-Occlusive Disease; Humans; Male; Retrospective Studies

2019
Sinusoidal obstruction syndrome during induction therapy for acute lymphoblastic leukemia managed with N-acetyl Cysteine.
    Pediatric blood & cancer, 2011, Volume: 57, Issue:4

    Topics: Acetylcysteine; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Dexamethasone; Epirubicin; Female; Fibrinolytic Agents; Hepatic Veno-Occlusive Disease; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sepsis; Young Adult

2011
N-acetylcysteine for hepatic veno-occlusive disease after allogeneic stem cell transplantation.
    Bone marrow transplantation, 2000, Volume: 25, Issue:9

    Topics: Acetylcysteine; Adult; Child; Cytokines; Female; Hematopoietic Stem Cell Transplantation; Hepatic Veno-Occlusive Disease; Humans; Male; Transplantation, Homologous

2000